Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER INC

End-of-day quote Nyse  -  21:31 29/11/2022 GMT
- USD    0.00%
11:30aImmutep Strikes Clinical Trial Collaboration with Merck, Pfizer for Urothelial Cancer Treatment
MT
11/28Immutep Enters second Collaboration with Pfizer and Merck KGaA
CI
11/28Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
BU
SummaryNewsRatingsCalendarCompanyFunds 
Days
:
Hours
:
Minutes
:
Seconds
Business Summary
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- vaccines (52.4%);

- drugs for the treatment of cancer (15.2%);

- cardiovascular, metabolic and analgesic drugs (11.5%);

- injectable, anti-infectives drugs and active pharmaceutical ingredients (9%);

- drugs for inflammatory and immune diseases (5.5%);

- drugs for rare diseases (4.4%);

- other (2%).

At the end of 2021, the group had more than 39 production sites worldwide.

Net sales are distributed geographically as follows: the United States (36.6%), Europe (22.6%) and other (40.8%).
Managers
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 59 2020
David Denton Chief Financial Officer & Executive Vice President 56 2022
Mikael Dolsten Executive VP, President-Research & Development 63 2010
Lidia Fonseca Executive VP, Chief Digital & Technology Officer 52 -
Aida Habtezion Chief Medical Officer - -
Annaliesa Anderson, Dr. VP, CSO-Bacterial Research & Hospital - -
Rady Johnson Executive VP, Chief Compliance & Risk Officer 60 2013
Bryan Dunn Investor Relations Contact - -
Christopher J. Stevo Senior Vice President - 2021
Margaret M. Madden Secretary, Chief Governance Counsel & Senior VP - -
Members of the board
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 59 2020
Suzanne Johnson Independent Director 64 2007
Helen H. Hobbs, Dr. Independent Director 68 2011
Shantanu Narayen Lead Independent Director 57 -
James Smith Independent Director 61 2014
Joseph Echevarria Independent Director 64 2015
Ronald E. Blaylock Independent Director 61 2017
Dan R. Littman, Dr. Independent Director 68 2018
James R. Quincey Independent Director 56 2020
Susan J. Hockfield, Dr. Independent Director 70 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,516,314,537 5,610,756,746 59.0% 3,903,000,000 41.0% 59.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 465,062,213 8.29%
SSgA Funds Management, Inc. 287,217,028 5.12%
Capital Research & Management Co. (World Investors) 250,126,747 4.46%
Wellington Management Co. LLP 219,171,647 3.91%
Capital Research & Management Co. 142,320,700 2.54%
BlackRock Fund Advisors 122,295,319 2.18%
Geode Capital Management LLC 108,582,838 1.93%
Northern Trust Investments, Inc.(Investment Management) 66,978,348 1.19%
Charles Schwab Investment Management, Inc. 64,122,012 1.14%
Norges Bank Investment Management 56,763,604 1.01%
Holdings
NameEquities%Valuation
PFIZER LIMITED (500680) 29,243,042 63.9% 1,547,158,406 USD
AKERO THERAPEUTICS, INC. (AKRO) 2,525,252 5.44% 106,717,150 USD
VALNEVA SE (VLA) 9,549,761 6.90% 64,615,975 USD
SPRINGWORKS THERAPEUTICS, INC. (SWTX) 2,340,330 3.75% 56,191,323 USD
SOSEI GROUP CORPORATION (4565) 1,885,136 2.30% 25,784,513 USD
BIOATLA, INC. (BCAB) 1,372,052 3.78% 9,453,438 USD
WAVE LIFE SCIENCES LTD. (WVE) 1,875,000 2.16% 8,981,250 USD
NEXTCURE, INC. (NXTC) 1,970,759 7.10% 4,926,898 USD
SPERO THERAPEUTICS, INC. (SPRO) 2,362,348 6.74% 4,630,202 USD
4D MOLECULAR THERAPEUTICS, INC. (FDMT) 341,658 1.06% 2,958,758 USD
Company contact information
Pfizer Inc.
235 East 42nd Street
New York, NY 10017-5755

Phone : +1.212.733.2323
Web : http://www.pfizer.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PFIZER INC278 252
JOHNSON & JOHNSON3.66%463 626
ELI LILLY AND COMPANY32.23%347 547
ABBVIE INC.17.01%280 085
PFIZER, INC.-16.05%278 252
MERCK & CO., INC.41.51%274 964
ROCHE HOLDING AG-17.59%271 275
NOVO NORDISK A/S16.79%270 881
ASTRAZENECA PLC27.33%205 902
NOVARTIS AG3.74%189 127
BRISTOL-MYERS SQUIBB COMPANY27.09%175 663
AMGEN INC.26.12%150 800
SANOFI-0.78%114 454
GILEAD SCIENCES, INC.18.80%106 874
GSK PLC-15.14%67 903
DAIICHI SANKYO CO., LTD.55.97%62 978
BAYER AG18.62%56 874
TAKEDA PHARMACEUTICAL COMPANY LIMITED28.66%45 183
CHUGAI PHARMACEUTICAL CO., LTD-2.14%43 297
JIANGSU HENGRUI MEDICINE CO., LTD.-22.74%34 668
ASTELLAS PHARMA INC.14.51%28 114